UK-US Trade Deal: How New Value Set For HTAs Will Impact UK Drug Pricing

NICE, the HTA body for England and Wales will implement a new value set for use in its evaluations in 2026. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Health Technology Assessment

More from Market Access